These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

208 related articles for article (PubMed ID: 10720643)

  • 1. Development of cardiomyocyte hypotrophy in rats under prolonged treatment with a low dose of a nitric oxide synthesis inhibitor.
    de Oliveira CF; Cintra KA; Teixeira SA; De Luca IM; Antunes E; De Nucci G
    Eur J Pharmacol; 2000 Mar; 391(1-2):121-6. PubMed ID: 10720643
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Attenuation of hypertension, cardiomyocyte hypertrophy, and myocardial fibrosis by beta-adrenoceptor blockers in rats under long-term blockade of nitric oxide synthesis.
    Pacca SR; de Azevedo AP; De Oliveira CF; De Luca IM; De Nucci G; Antunes E
    J Cardiovasc Pharmacol; 2002 Feb; 39(2):201-7. PubMed ID: 11791005
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Chronic inhibition of nitric oxide synthase induces hypertension and cardiomyocyte mitochondrial and myocardial collagen remodelling in the absence of hypertrophy.
    Rossi MA; Ramos SG; Prado CM
    J Hypertens; 2003 May; 21(5):993-1001. PubMed ID: 12714875
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cardiovascular effects of chronic nitric oxide synthase inhibition in genetically hypertensive rats.
    Orange SJ; Ledingham JM; Laverty R
    Clin Exp Pharmacol Physiol; 2000 Jul; 27(7):488-93. PubMed ID: 10874504
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of simvastatin on remodeling of the left ventricle and aorta in L-NAME-induced hypertension.
    Simko F; Matuskova J; Luptak I; Krajcirovicova K; Kucharska J; Gvozdjakova A; Babal P; Pechanova O
    Life Sci; 2004 Jan; 74(10):1211-24. PubMed ID: 14697405
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Chronic inhibition of nitric oxide synthesis causes coronary microvascular remodeling in rats.
    Numaguchi K; Egashira K; Takemoto M; Kadokami T; Shimokawa H; Sueishi K; Takeshita A
    Hypertension; 1995 Dec; 26(6 Pt 1):957-62. PubMed ID: 7490155
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Upregulation of adrenomedullin and its receptor components during cardiomyocyte hypertrophy induced by chronic inhibition of nitric oxide synthesis in rats.
    Bell D; Zhao YY; Kelso EJ; McHenry EM; Rush LM; Lamont VM; Nicholls DP; McDermott BJ
    Am J Physiol Heart Circ Physiol; 2006 Feb; 290(2):H904-14. PubMed ID: 16040721
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Structural alterations in the heart after long-term L-NAME and D-NAME treatment.
    Pechánová O; Bernátová I; Babál P
    Gen Physiol Biophys; 1999 Dec; 18 Suppl 1():6-9. PubMed ID: 10707823
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Role of kinins and nitric oxide in the antihypertrophic effect of ramipril.
    Rhaleb NE; Yang XP; Scicli AG; Carretero OA
    Hypertension; 1994 Jun; 23(6 Pt 2):865-8. PubMed ID: 7515854
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of chronic inhibition of nitric oxide synthase in the genetically hypertensive rat.
    Tucker EJ; Ledingham JM; Zheng Y; Laverty R
    Clin Exp Pharmacol Physiol; 2000 Aug; 27(8):647-9. PubMed ID: 10901399
    [TBL] [Abstract][Full Text] [Related]  

  • 11. L-arginine fails to protect against myocardial remodelling in L-NAME-induced hypertension.
    Simko F; Luptak I; Matuskova J; Krajcirovicova K; Sumbalova Z; Kucharska J; Gvozdjakova A; Simko J; Babal P; Pechanova O; Bernatova I
    Eur J Clin Invest; 2005 Jun; 35(6):362-8. PubMed ID: 15948896
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Left ventricular adaptation to chronic pressure overload induced by inhibition of nitric oxide synthase in rats.
    Matsubara BB; Matsubara LS; Zornoff LA; Franco M; Janicki JS
    Basic Res Cardiol; 1998 Jun; 93(3):173-81. PubMed ID: 9689443
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Malignant alterations following early blockade of nitric oxide synthase in hypertensive rats.
    Hsu YH; Hsu BG; Chen HI
    Chin J Physiol; 2007 Dec; 50(6):283-93. PubMed ID: 18442011
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Chronic low-dose L-NAME treatment effect on cardiovascular system of borderline hypertensive rats: feedback regulation?
    Kopincova J; Puzserova A; Bernatova I
    Neuro Endocrinol Lett; 2008 Oct; 29(5):784-9. PubMed ID: 18987608
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Protective effects of BAY 41-2272 (sGC stimulator) on hypertension, heart, and cardiomyocyte hypertrophy induced by chronic L-NAME treatment in rats.
    Zanfolin M; Faro R; Araujo EG; Guaraldo AM; Antunes E; De Nucci G
    J Cardiovasc Pharmacol; 2006 Mar; 47(3):391-5. PubMed ID: 16633081
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Regression of chronic L -NAME-treatment-induced left ventricular hypertrophy: effect of captopril.
    Bernátová I; Pechánová O; Pelouch V; Simko F
    J Mol Cell Cardiol; 2000 Feb; 32(2):177-85. PubMed ID: 10722795
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of bradykinin on cardiovascular remodeling in renovascular hypertensive rats.
    Tanaka Y; Nagai M; Date T; Okada T; Abe Y; Seki S; Taniguchi M; Taniguchi I; Mochizuki S
    Hypertens Res; 2004 Nov; 27(11):865-75. PubMed ID: 15824469
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Differential subcellular actions of ACE inhibitors and AT(1) receptor antagonists on cardiac remodeling induced by chronic inhibition of NO synthesis in rats.
    Sanada S; Kitakaze M; Node K; Takashima S; Ogai A; Asanuma H; Sakata Y; Asakura M; Ogita H; Liao Y; Fukushima T; Yamada J; Minamino T; Kuzuya T; Hori M
    Hypertension; 2001 Sep; 38(3):404-11. PubMed ID: 11566913
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Captopril prevents NO-deficient hypertension and left ventricular hypertrophy without affecting nitric oxide synthase activity in rats.
    Bernátová I; Pechánová O; Simko F
    Physiol Res; 1996; 45(4):311-6. PubMed ID: 9085355
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Numerical density of cardiomyocytes in chronic nitric oxide synthesis inhibition.
    Mandarim-De-Lacerda CA; Meirelles Pereira LM
    Pathobiology; 2000; 68(1):36-42. PubMed ID: 10859529
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.